Suchergebnisse - (Person:"Mo, Hongnan")

PubPharm (3)

1

Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer : A prospective study

enthalten in: Thoracic cancer | 2024

von Wu, Y. | Mo, H. | Xu, H. | +4

2

Prognostic and predictive impact of neutrophil-to-lymphocyte ratio and HLA-I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapy

enthalten in: Thoracic cancer | 2022

von Wang, L. | Zhu, Y. | Zhang, B. | +5

3

Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody

enthalten in: Thoracic cancer | 2019

von Wang, X. | Zhang, B. | Chen, X. | +6

1
[1]